LKK123的个人主页 - 老虎社区

LKK123

LKK123

暂无个人介绍

IP属地：海外

815关注

19粉丝

0主题

0勋章

2022-09-23

好

@问就是加仓up:写在腾讯股价创近四年新低之际

2021-11-11

这篇文章不错，转发给大家看

@四叶草们:$Bank of America(BAC)$M

2021-11-11

这篇文章不错，转发给大家看

@10f6ccb4:$Bank of America(BAC)$[微笑]

2021-08-16

hi

抱歉，原内容已删除

2021-08-14

hi

抱歉，原内容已删除

2021-08-13

等等

抱歉，原内容已删除

2021-08-12

hi

BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4090580149975460","uuid":"4090580149975460","gmtCreate":1627478738972,"gmtModify":1706620619446,"name":"LKK123","pinyin":"lkk123","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":19,"headSize":815,"tweetSize":7,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.04.24","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.34%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"海外","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":661641403,"gmtCreate":1663913568603,"gmtModify":1663913571224,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090580149975460","idStr":"4090580149975460"},"themes":[],"htmlText":"好","listText":"好","text":"好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/661641403","repostId":"661121977","repostType":1,"repost":{"id":661121977,"gmtCreate":1663773601200,"gmtModify":1663774713799,"author":{"id":"3548388348794551","authorId":"3548388348794551","name":"问就是加仓up","avatar":"https://static.tigerbbs.com/4e98ddf789d46c5627f944fc581c0fe9","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3548388348794551","idStr":"3548388348794551"},"themes":[],"title":"写在腾讯股价创近四年新低之际","htmlText":"今天盘中腾讯股价再次跌2%,股价几乎创近4年新低，相比于之前跌破300港币无数人疾呼抄底，这次明显安静了很多，氛围感也没有了，毕竟上半年港股急跌以腾讯跌破300港币收尾。这次，又会怎么走？ 本文仅为个人投资思考记录，不构成任何投资建议，格局不同，立场不同，仅供参考。 就在一年多以前，在全球牛市的衬托下，国内基金振臂高呼跨过香江争夺定价权，腾讯连续日内10%的涨幅拉升，股价一度接近750港币，当时的口号是1000港币不是梦，不是我在这瞎吹，我当时还买了800港币的涡轮，当时觉得突破1000不算啥事。随后没几天就开始掉转形式向下，开启了无限的下跌，绵延至今。从月线可以看出，这一路没有特别暴力的反弹。 目前腾讯股价的下跌主要几个原因，最最主要的其实是大股东的减持，港股的流动性虽然 很差，但是以腾讯的声望，还是有很多的资金在不断抄底，但是一旦有人开始稳定持续的减持，对股价的影响那就容易倾斜，在大股东减持之前，其实股价本就处于弱平衡之下，腾讯目前每天也是在稳定回购，回购金额约占当日成交金额的十分之一以下，目前无法看到大股东每日减持明细，因为每减持1%的股份才会发布一次减持公告，上次发布是9.8日的时候，当时持股降到了27.96%，下次公告是持股减持到27%以下的时候，即在减持9600w股，今天腾讯成交了1600w股，我没查到港股减持的规则，假设每天减持200w股，大约需要45多个交易日，上次大股东转入了1.9亿股，全部减持完大概需要100个交易日。 而且这是算术的角度看，从理性的角度看，大股东肯定想要卖个好价钱 ，不可能无脑卖出，所以股价跌得多了，卖出速度会变慢。这些股份大概率是要全部卖出的，基本上意味着未来大半年腾讯的股价基本上会承受非常大的压力，如果你不知道什么叫压力，最近一个月的走势就是压力。 大股东的抛售金额大概率是高于每天腾讯自身回购的金额，所以你可以将这个回购行为的价值","listText":"今天盘中腾讯股价再次跌2%,股价几乎创近4年新低，相比于之前跌破300港币无数人疾呼抄底，这次明显安静了很多，氛围感也没有了，毕竟上半年港股急跌以腾讯跌破300港币收尾。这次，又会怎么走？ 本文仅为个人投资思考记录，不构成任何投资建议，格局不同，立场不同，仅供参考。 就在一年多以前，在全球牛市的衬托下，国内基金振臂高呼跨过香江争夺定价权，腾讯连续日内10%的涨幅拉升，股价一度接近750港币，当时的口号是1000港币不是梦，不是我在这瞎吹，我当时还买了800港币的涡轮，当时觉得突破1000不算啥事。随后没几天就开始掉转形式向下，开启了无限的下跌，绵延至今。从月线可以看出，这一路没有特别暴力的反弹。 目前腾讯股价的下跌主要几个原因，最最主要的其实是大股东的减持，港股的流动性虽然 很差，但是以腾讯的声望，还是有很多的资金在不断抄底，但是一旦有人开始稳定持续的减持，对股价的影响那就容易倾斜，在大股东减持之前，其实股价本就处于弱平衡之下，腾讯目前每天也是在稳定回购，回购金额约占当日成交金额的十分之一以下，目前无法看到大股东每日减持明细，因为每减持1%的股份才会发布一次减持公告，上次发布是9.8日的时候，当时持股降到了27.96%，下次公告是持股减持到27%以下的时候，即在减持9600w股，今天腾讯成交了1600w股，我没查到港股减持的规则，假设每天减持200w股，大约需要45多个交易日，上次大股东转入了1.9亿股，全部减持完大概需要100个交易日。 而且这是算术的角度看，从理性的角度看，大股东肯定想要卖个好价钱 ，不可能无脑卖出，所以股价跌得多了，卖出速度会变慢。这些股份大概率是要全部卖出的，基本上意味着未来大半年腾讯的股价基本上会承受非常大的压力，如果你不知道什么叫压力，最近一个月的走势就是压力。 大股东的抛售金额大概率是高于每天腾讯自身回购的金额，所以你可以将这个回购行为的价值","text":"今天盘中腾讯股价再次跌2%,股价几乎创近4年新低，相比于之前跌破300港币无数人疾呼抄底，这次明显安静了很多，氛围感也没有了，毕竟上半年港股急跌以腾讯跌破300港币收尾。这次，又会怎么走？ 本文仅为个人投资思考记录，不构成任何投资建议，格局不同，立场不同，仅供参考。 就在一年多以前，在全球牛市的衬托下，国内基金振臂高呼跨过香江争夺定价权，腾讯连续日内10%的涨幅拉升，股价一度接近750港币，当时的口号是1000港币不是梦，不是我在这瞎吹，我当时还买了800港币的涡轮，当时觉得突破1000不算啥事。随后没几天就开始掉转形式向下，开启了无限的下跌，绵延至今。从月线可以看出，这一路没有特别暴力的反弹。 目前腾讯股价的下跌主要几个原因，最最主要的其实是大股东的减持，港股的流动性虽然 很差，但是以腾讯的声望，还是有很多的资金在不断抄底，但是一旦有人开始稳定持续的减持，对股价的影响那就容易倾斜，在大股东减持之前，其实股价本就处于弱平衡之下，腾讯目前每天也是在稳定回购，回购金额约占当日成交金额的十分之一以下，目前无法看到大股东每日减持明细，因为每减持1%的股份才会发布一次减持公告，上次发布是9.8日的时候，当时持股降到了27.96%，下次公告是持股减持到27%以下的时候，即在减持9600w股，今天腾讯成交了1600w股，我没查到港股减持的规则，假设每天减持200w股，大约需要45多个交易日，上次大股东转入了1.9亿股，全部减持完大概需要100个交易日。 而且这是算术的角度看，从理性的角度看，大股东肯定想要卖个好价钱 ，不可能无脑卖出，所以股价跌得多了，卖出速度会变慢。这些股份大概率是要全部卖出的，基本上意味着未来大半年腾讯的股价基本上会承受非常大的压力，如果你不知道什么叫压力，最近一个月的走势就是压力。 大股东的抛售金额大概率是高于每天腾讯自身回购的金额，所以你可以将这个回购行为的价值","images":[],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/661121977","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1115,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870117527,"gmtCreate":1636593239582,"gmtModify":1636593239686,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090580149975460","idStr":"4090580149975460"},"themes":[],"htmlText":"这篇文章不错，转发给大家看","listText":"这篇文章不错，转发给大家看","text":"这篇文章不错，转发给大家看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870117527","repostId":"870133060","repostType":1,"repost":{"id":870133060,"gmtCreate":1636592186291,"gmtModify":1636592186501,"author":{"id":"3571323030005470","authorId":"3571323030005470","name":"四叶草们","avatar":"https://static.tigerbbs.com/0334c25504d77d28ac47180d08a58e9e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3571323030005470","idStr":"3571323030005470"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BAC\">$Bank of America(BAC)$</a>M","listText":"<a href=\"https://laohu8.com/S/BAC\">$Bank of America(BAC)$</a>M","text":"$Bank of America(BAC)$M","images":[{"img":"https://static.tigerbbs.com/491002eeaa71d5c28bf9223f78607a8a","width":"1284","height":"2538"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870133060","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":750,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870114433,"gmtCreate":1636593168460,"gmtModify":1636593168567,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090580149975460","idStr":"4090580149975460"},"themes":[],"htmlText":"这篇文章不错，转发给大家看","listText":"这篇文章不错，转发给大家看","text":"这篇文章不错，转发给大家看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870114433","repostId":"870195794","repostType":1,"repost":{"id":870195794,"gmtCreate":1636591964805,"gmtModify":1636591964888,"author":{"id":"3585607107146910","authorId":"3585607107146910","name":"10f6ccb4","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585607107146910","idStr":"3585607107146910"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BAC\">$Bank of America(BAC)$</a>[微笑]&nbsp;","listText":"<a href=\"https://laohu8.com/S/BAC\">$Bank of America(BAC)$</a>[微笑]&nbsp;","text":"$Bank of America(BAC)$[微笑]","images":[{"img":"https://static.tigerbbs.com/8e084def90af6e4ada04717b2b3551f0","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870195794","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1675,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":839025059,"gmtCreate":1629109165371,"gmtModify":1633687350961,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090580149975460","idStr":"4090580149975460"},"themes":[],"htmlText":"hi","listText":"hi","text":"hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/839025059","repostId":"2159248377","repostType":4,"isVote":1,"tweetType":1,"viewCount":379,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":897615623,"gmtCreate":1628911932562,"gmtModify":1633688538882,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090580149975460","idStr":"4090580149975460"},"themes":[],"htmlText":"hi","listText":"hi","text":"hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/897615623","repostId":"2159321505","repostType":4,"isVote":1,"tweetType":1,"viewCount":256,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":894463697,"gmtCreate":1628848657319,"gmtModify":1633689023356,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090580149975460","idStr":"4090580149975460"},"themes":[],"htmlText":"等等","listText":"等等","text":"等等","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/894463697","repostId":"2159296424","repostType":4,"isVote":1,"tweetType":1,"viewCount":809,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":894033074,"gmtCreate":1628777028198,"gmtModify":1633689581594,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090580149975460","idStr":"4090580149975460"},"themes":[],"htmlText":"hi","listText":"hi","text":"hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/894033074","repostId":"2158325931","repostType":4,"repost":{"id":"2158325931","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628776169,"share":"https://www.laohu8.com/m/news/2158325931?lang=&edition=full","pubTime":"2021-08-12 21:49","market":"us","language":"en","title":"BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster","url":"https://stock-news.laohu8.com/highlight/detail?id=2158325931","media":"Tiger Newspress","summary":"BioNTech and Moderna stock rose in early trading on Thursday, on track to recover some of the previo","content":"<p>BioNTech&nbsp;and Moderna&nbsp;stock rose in&nbsp;early&nbsp;trading&nbsp;on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.</p>\n<p><img src=\"https://static.tigerbbs.com/2860e1c0dcbf5f35624516c9d0ff29db\" tg-width=\"895\" tg-height=\"647\" width=\"100%\" height=\"auto\"></p>\n<p>BioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.</p>\n<p>The WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.</p>\n<p>There is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.</p>\n<p>BioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.</p>\n<p>The conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.</p>\n<p>Pfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-12 21:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BioNTech&nbsp;and Moderna&nbsp;stock rose in&nbsp;early&nbsp;trading&nbsp;on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.</p>\n<p><img src=\"https://static.tigerbbs.com/2860e1c0dcbf5f35624516c9d0ff29db\" tg-width=\"895\" tg-height=\"647\" width=\"100%\" height=\"auto\"></p>\n<p>BioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.</p>\n<p>The WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.</p>\n<p>There is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.</p>\n<p>BioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.</p>\n<p>The conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.</p>\n<p>Pfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","MRNA":"Moderna, Inc.","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158325931","content_text":"BioNTech and Moderna stock rose in early trading on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.\n\nBioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.\nThe WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.\nThere is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.\nBioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.\nThe conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.\nPfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.","news_type":1},"isVote":1,"tweetType":1,"viewCount":237,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":897615623,"gmtCreate":1628911932562,"gmtModify":1633688538882,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090580149975460","authorIdStr":"4090580149975460"},"themes":[],"htmlText":"hi","listText":"hi","text":"hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/897615623","repostId":"2159321505","repostType":4,"isVote":1,"tweetType":1,"viewCount":256,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":839025059,"gmtCreate":1629109165371,"gmtModify":1633687350961,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090580149975460","authorIdStr":"4090580149975460"},"themes":[],"htmlText":"hi","listText":"hi","text":"hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/839025059","repostId":"2159248377","repostType":4,"isVote":1,"tweetType":1,"viewCount":379,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":894033074,"gmtCreate":1628777028198,"gmtModify":1633689581594,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090580149975460","authorIdStr":"4090580149975460"},"themes":[],"htmlText":"hi","listText":"hi","text":"hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/894033074","repostId":"2158325931","repostType":4,"repost":{"id":"2158325931","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628776169,"share":"https://www.laohu8.com/m/news/2158325931?lang=&edition=full","pubTime":"2021-08-12 21:49","market":"us","language":"en","title":"BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster","url":"https://stock-news.laohu8.com/highlight/detail?id=2158325931","media":"Tiger Newspress","summary":"BioNTech and Moderna stock rose in early trading on Thursday, on track to recover some of the previo","content":"<p>BioNTech&nbsp;and Moderna&nbsp;stock rose in&nbsp;early&nbsp;trading&nbsp;on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.</p>\n<p><img src=\"https://static.tigerbbs.com/2860e1c0dcbf5f35624516c9d0ff29db\" tg-width=\"895\" tg-height=\"647\" width=\"100%\" height=\"auto\"></p>\n<p>BioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.</p>\n<p>The WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.</p>\n<p>There is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.</p>\n<p>BioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.</p>\n<p>The conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.</p>\n<p>Pfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech, Moderna Gain on Report of FDA’s Likely Nod for Booster\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-12 21:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BioNTech&nbsp;and Moderna&nbsp;stock rose in&nbsp;early&nbsp;trading&nbsp;on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.</p>\n<p><img src=\"https://static.tigerbbs.com/2860e1c0dcbf5f35624516c9d0ff29db\" tg-width=\"895\" tg-height=\"647\" width=\"100%\" height=\"auto\"></p>\n<p>BioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.</p>\n<p>The WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.</p>\n<p>There is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.</p>\n<p>BioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.</p>\n<p>The conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.</p>\n<p>Pfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","MRNA":"Moderna, Inc.","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158325931","content_text":"BioNTech and Moderna stock rose in early trading on Thursday, on track to recover some of the previous session’s losses, following a report in the Wall Street Journal that the FDA could authorize Covid-19 booster shots for immunocompromised people.\n\nBioNTech and Moderna were up 3.96% and 2% after plunging 14% and 15.6% in the previous session, respectively. Pfizer (NYSE:PFE), which shed 4% on Wednesday, was up 1%.\nThe WSJ reported that the Food and Drug Administration is nearing a decision to authorize booster shots for people with weak immunity amid a surge in new COVID cases because of the rapid spread of the delta variant.\nThere is growing evidence that two shots of the vaccines are inadequate for people with low immunity. Vaccine makers plan to approach the FDA this month or next for approval to their booster shots.\nBioNTech, Moderna and Pfizer all closed lower Wednesday following news that Europe’s drug regulator is studying three new conditions reported by a small number of people after getting Covid-19 shots to assess if they may be possible side-effects.\nThe conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.\nPfizer and BioNTech are collaborating on the research and marketing of their COVID-19 vaccine. Expenses and profit from the vaccine are split equally between Pfizer and BioNTech.","news_type":1},"isVote":1,"tweetType":1,"viewCount":237,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":894463697,"gmtCreate":1628848657319,"gmtModify":1633689023356,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090580149975460","authorIdStr":"4090580149975460"},"themes":[],"htmlText":"等等","listText":"等等","text":"等等","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/894463697","repostId":"2159296424","repostType":4,"isVote":1,"tweetType":1,"viewCount":809,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870117527,"gmtCreate":1636593239582,"gmtModify":1636593239686,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090580149975460","authorIdStr":"4090580149975460"},"themes":[],"htmlText":"这篇文章不错，转发给大家看","listText":"这篇文章不错，转发给大家看","text":"这篇文章不错，转发给大家看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870117527","repostId":"870133060","repostType":1,"repost":{"id":870133060,"gmtCreate":1636592186291,"gmtModify":1636592186501,"author":{"id":"3571323030005470","authorId":"3571323030005470","name":"四叶草们","avatar":"https://static.tigerbbs.com/0334c25504d77d28ac47180d08a58e9e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571323030005470","authorIdStr":"3571323030005470"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BAC\">$Bank of America(BAC)$</a>M","listText":"<a href=\"https://laohu8.com/S/BAC\">$Bank of America(BAC)$</a>M","text":"$Bank of America(BAC)$M","images":[{"img":"https://static.tigerbbs.com/491002eeaa71d5c28bf9223f78607a8a","width":"1284","height":"2538"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870133060","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":750,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870114433,"gmtCreate":1636593168460,"gmtModify":1636593168567,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090580149975460","authorIdStr":"4090580149975460"},"themes":[],"htmlText":"这篇文章不错，转发给大家看","listText":"这篇文章不错，转发给大家看","text":"这篇文章不错，转发给大家看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870114433","repostId":"870195794","repostType":1,"repost":{"id":870195794,"gmtCreate":1636591964805,"gmtModify":1636591964888,"author":{"id":"3585607107146910","authorId":"3585607107146910","name":"10f6ccb4","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585607107146910","authorIdStr":"3585607107146910"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BAC\">$Bank of America(BAC)$</a>[微笑]&nbsp;","listText":"<a href=\"https://laohu8.com/S/BAC\">$Bank of America(BAC)$</a>[微笑]&nbsp;","text":"$Bank of America(BAC)$[微笑]","images":[{"img":"https://static.tigerbbs.com/8e084def90af6e4ada04717b2b3551f0","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870195794","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1675,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":661641403,"gmtCreate":1663913568603,"gmtModify":1663913571224,"author":{"id":"4090580149975460","authorId":"4090580149975460","name":"LKK123","avatar":"https://static.tigerbbs.com/c47db5a7dcd09232dd68caffa1b258d4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090580149975460","authorIdStr":"4090580149975460"},"themes":[],"htmlText":"好","listText":"好","text":"好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/661641403","repostId":"661121977","repostType":1,"repost":{"id":661121977,"gmtCreate":1663773601200,"gmtModify":1663774713799,"author":{"id":"3548388348794551","authorId":"3548388348794551","name":"问就是加仓up","avatar":"https://static.tigerbbs.com/4e98ddf789d46c5627f944fc581c0fe9","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3548388348794551","authorIdStr":"3548388348794551"},"themes":[],"title":"写在腾讯股价创近四年新低之际","htmlText":"今天盘中腾讯股价再次跌2%,股价几乎创近4年新低，相比于之前跌破300港币无数人疾呼抄底，这次明显安静了很多，氛围感也没有了，毕竟上半年港股急跌以腾讯跌破300港币收尾。这次，又会怎么走？ 本文仅为个人投资思考记录，不构成任何投资建议，格局不同，立场不同，仅供参考。 就在一年多以前，在全球牛市的衬托下，国内基金振臂高呼跨过香江争夺定价权，腾讯连续日内10%的涨幅拉升，股价一度接近750港币，当时的口号是1000港币不是梦，不是我在这瞎吹，我当时还买了800港币的涡轮，当时觉得突破1000不算啥事。随后没几天就开始掉转形式向下，开启了无限的下跌，绵延至今。从月线可以看出，这一路没有特别暴力的反弹。 目前腾讯股价的下跌主要几个原因，最最主要的其实是大股东的减持，港股的流动性虽然 很差，但是以腾讯的声望，还是有很多的资金在不断抄底，但是一旦有人开始稳定持续的减持，对股价的影响那就容易倾斜，在大股东减持之前，其实股价本就处于弱平衡之下，腾讯目前每天也是在稳定回购，回购金额约占当日成交金额的十分之一以下，目前无法看到大股东每日减持明细，因为每减持1%的股份才会发布一次减持公告，上次发布是9.8日的时候，当时持股降到了27.96%，下次公告是持股减持到27%以下的时候，即在减持9600w股，今天腾讯成交了1600w股，我没查到港股减持的规则，假设每天减持200w股，大约需要45多个交易日，上次大股东转入了1.9亿股，全部减持完大概需要100个交易日。 而且这是算术的角度看，从理性的角度看，大股东肯定想要卖个好价钱 ，不可能无脑卖出，所以股价跌得多了，卖出速度会变慢。这些股份大概率是要全部卖出的，基本上意味着未来大半年腾讯的股价基本上会承受非常大的压力，如果你不知道什么叫压力，最近一个月的走势就是压力。 大股东的抛售金额大概率是高于每天腾讯自身回购的金额，所以你可以将这个回购行为的价值","listText":"今天盘中腾讯股价再次跌2%,股价几乎创近4年新低，相比于之前跌破300港币无数人疾呼抄底，这次明显安静了很多，氛围感也没有了，毕竟上半年港股急跌以腾讯跌破300港币收尾。这次，又会怎么走？ 本文仅为个人投资思考记录，不构成任何投资建议，格局不同，立场不同，仅供参考。 就在一年多以前，在全球牛市的衬托下，国内基金振臂高呼跨过香江争夺定价权，腾讯连续日内10%的涨幅拉升，股价一度接近750港币，当时的口号是1000港币不是梦，不是我在这瞎吹，我当时还买了800港币的涡轮，当时觉得突破1000不算啥事。随后没几天就开始掉转形式向下，开启了无限的下跌，绵延至今。从月线可以看出，这一路没有特别暴力的反弹。 目前腾讯股价的下跌主要几个原因，最最主要的其实是大股东的减持，港股的流动性虽然 很差，但是以腾讯的声望，还是有很多的资金在不断抄底，但是一旦有人开始稳定持续的减持，对股价的影响那就容易倾斜，在大股东减持之前，其实股价本就处于弱平衡之下，腾讯目前每天也是在稳定回购，回购金额约占当日成交金额的十分之一以下，目前无法看到大股东每日减持明细，因为每减持1%的股份才会发布一次减持公告，上次发布是9.8日的时候，当时持股降到了27.96%，下次公告是持股减持到27%以下的时候，即在减持9600w股，今天腾讯成交了1600w股，我没查到港股减持的规则，假设每天减持200w股，大约需要45多个交易日，上次大股东转入了1.9亿股，全部减持完大概需要100个交易日。 而且这是算术的角度看，从理性的角度看，大股东肯定想要卖个好价钱 ，不可能无脑卖出，所以股价跌得多了，卖出速度会变慢。这些股份大概率是要全部卖出的，基本上意味着未来大半年腾讯的股价基本上会承受非常大的压力，如果你不知道什么叫压力，最近一个月的走势就是压力。 大股东的抛售金额大概率是高于每天腾讯自身回购的金额，所以你可以将这个回购行为的价值","text":"今天盘中腾讯股价再次跌2%,股价几乎创近4年新低，相比于之前跌破300港币无数人疾呼抄底，这次明显安静了很多，氛围感也没有了，毕竟上半年港股急跌以腾讯跌破300港币收尾。这次，又会怎么走？ 本文仅为个人投资思考记录，不构成任何投资建议，格局不同，立场不同，仅供参考。 就在一年多以前，在全球牛市的衬托下，国内基金振臂高呼跨过香江争夺定价权，腾讯连续日内10%的涨幅拉升，股价一度接近750港币，当时的口号是1000港币不是梦，不是我在这瞎吹，我当时还买了800港币的涡轮，当时觉得突破1000不算啥事。随后没几天就开始掉转形式向下，开启了无限的下跌，绵延至今。从月线可以看出，这一路没有特别暴力的反弹。 目前腾讯股价的下跌主要几个原因，最最主要的其实是大股东的减持，港股的流动性虽然 很差，但是以腾讯的声望，还是有很多的资金在不断抄底，但是一旦有人开始稳定持续的减持，对股价的影响那就容易倾斜，在大股东减持之前，其实股价本就处于弱平衡之下，腾讯目前每天也是在稳定回购，回购金额约占当日成交金额的十分之一以下，目前无法看到大股东每日减持明细，因为每减持1%的股份才会发布一次减持公告，上次发布是9.8日的时候，当时持股降到了27.96%，下次公告是持股减持到27%以下的时候，即在减持9600w股，今天腾讯成交了1600w股，我没查到港股减持的规则，假设每天减持200w股，大约需要45多个交易日，上次大股东转入了1.9亿股，全部减持完大概需要100个交易日。 而且这是算术的角度看，从理性的角度看，大股东肯定想要卖个好价钱 ，不可能无脑卖出，所以股价跌得多了，卖出速度会变慢。这些股份大概率是要全部卖出的，基本上意味着未来大半年腾讯的股价基本上会承受非常大的压力，如果你不知道什么叫压力，最近一个月的走势就是压力。 大股东的抛售金额大概率是高于每天腾讯自身回购的金额，所以你可以将这个回购行为的价值","images":[],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/661121977","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1115,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}